Clinical Trial Update: Effect of Intravenous Amantadine on Gait Freezing in Parkinson's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intravenous amantadine for gait freezing in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• amantadine (intravenous) (amantadine)

Snippet

Sponsor: Jee-Young Lee | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED